Pyroptosis: a new paradigm of cell death for fighting against cancer.
Pyroptosis: a new paradigm of cell death for fighting against cancer.
复制标题
细胞焦亡:对抗癌症的细胞死亡新范例
DOI:
10.1186/s13046-021-01959-x
复制
发表时间:
2021-05-03
期刊:
影响因子:
--
通讯作者:
Yi M
中科院分区:
文献类型:
--
作者:
Tan Y;Chen Q;Li X;Zeng Z;Xiong W;Li G;Li X;Yang J;Xiang B;Yi M
Unraveling the mystery of cell death is one of the most fundamental progresses of life sciences during the past decades. Regulated cell death (RCD) or programmed cell death (PCD) is not only essential in embryonic development, but also plays an important role in the occurrence and progression of diseases, especially cancers. Escaping of cell death is one of hallmarks of cancer. Pyroptosis is an inflammatory cell death usually caused by microbial infection, accompanied by activation of inflammasomes and maturation of pro-inflammatory cytokines interleukin-1β (IL-1β) and interleukin-18 (IL-18). Gasdermin family proteins are the executors of pyroptosis. Cytotoxic N-terminal of gasdermins generated from caspases or granzymes proteases mediated cleavage of gasdermin proteins oligomerizes and forms pore across cell membrane, leading to release of IL-1β, IL-18. Pyroptosis exerts tumor suppression function and evokes anti-tumor immune responses. Therapeutic regimens, including chemotherapy, radiotherapy, targeted therapy and immune therapy, induce pyroptosis in cancer, which potentiate local and systemic anti-tumor immunity. On the other hand, pyroptosis of normal cells attributes to side effects of anti-cancer therapies. In this review, we focus on the regulatory mechanisms of pyroptosis and the tumor suppressive function of pyroptosis. We discuss the attribution of pyroptosis in reprogramming tumor microenvironments and restoration of anti-tumor immunity and its potential application in cancer immune therapy.
登录
查看更多内容
影响因子:
4.6
作者:
Crittenden MR;Zebertavage L;Kramer G;Bambina S;Friedman D;Troesch V;Blair T;Baird JR;Alice A;Gough MJ
通讯作者:
Gough MJ
影响因子:
32.4
作者:
Evavold CL;Ruan J;Tan Y;Xia S;Wu H;Kagan JC
通讯作者:
Kagan JC
影响因子:
82.9
作者:
Binnewies M;Roberts EW;Kersten K;Chan V;Fearon DF;Merad M;Coussens LM;Gabrilovich DI;Ostrand-Rosenberg S;Hedrick CC;Vonderheide RH;Pittet MJ;Jain RK;Zou W;Howcroft TK;Woodhouse EC;Weinberg RA;Krummel MF
通讯作者:
Krummel MF
影响因子:
7.2
作者:
Golden EB;Frances D;Pellicciotta I;Demaria S;Helen Barcellos-Hoff M;Formenti SC
通讯作者:
Formenti SC
DOI:
10.1084/jem.20100050
发表时间:
2010-05-10
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Allen IC;TeKippe EM;Woodford RM;Uronis JM;Holl EK;Rogers AB;Herfarth HH;Jobin C;Ting JP
通讯作者:
Ting JP